Achimhae Medical Devices Expresses Regret Over Livesmed's Unilateral Claims... Patent Trial Proceeding Without Issues

Achimhae Medical Devices stated on July 21, "The patent invalidation trial initiated by Livesmed is proceeding normally," adding, "We deeply regret Livesmed's attempt to sway public opinion through unilateral claims."

On the same day, Livesmed announced that it had filed for a patent invalidation trial in response to the patent infringement lawsuit brought against it by Achimhae Medical Devices. Livesmed also claimed that Achimhae Medical Devices was delaying the process or displaying an uncooperative attitude during the proceedings.

A representative from Achimhae Medical Devices said, "We submitted a thorough response on July 16 without filing a correction request, with the intention of responding to the patent invalidation trial initiated by Livesmed. All procedures are proceeding normally in accordance with the expedited trial system of the Intellectual Property Trial and Appeal Board," and added, "We are responding strictly after sufficient legal review and consultation."

The representative continued, "We are deeply concerned about Livesmed issuing press releases that are not based on facts related to the lawsuit. Patent disputes should be resolved through legal procedures, and actions that cause confusion through unilateral interpretations and distorted claims are by no means desirable."

Since its establishment in 2014, Achimhae Medical Devices has developed and manufactured a variety of medical devices, including multiple patents related to joint-type laparoscopic technology, as well as orthopedic and body correction devices, implants, surgical instruments, and laparoscopic equipment.

The company holds numerous quality certifications that meet global standards, such as the U.S. Food and Drug Administration (FDA) 510(k), European Union CE certification, and the international standard ISO 13485 for medical device quality management systems. Achimhae Medical Devices has continued its business in domestic and overseas markets based on its export competitiveness, including winning the Export Tower Award on Trade Day in 2022.

A company official stated, "We are actively conducting business in over 30 countries based on domestic and international patents and certifications," and added, "This patent infringement lawsuit is a legitimate procedure to protect the rights of our patents." The official emphasized, "We will continue to take necessary actions to protect our technological competitiveness and intellectual property rights in the future."

This content was produced with the assistance of AI translation services.